Key result
STING deficiency reduces cardiac inflammation and improves viral myocarditis survival in mice by suppressing macrophage activation.
Why the study?
The involvement and mechanism of myocardial damage in CVB3-induced viral myocarditis remain unclear.
Does STING deficiency reduce cardiac inflammation and improve survival in murine models of CVB3-induced viral myocarditis?
Does STING deficiency reduce cardiac inflammation and improve survival in murine models of CVB3-induced viral myocarditis?
Myocardial mtDNA drives macrophage inflammation via STING signaling in CVB3-induced viral myocarditis, identifying STING as a potential therapeutic target.
STING inhibition merits exploration in viral myocarditis; leaves open translation from murine models to human therapy.
Coxsackievirus B3 (CVB3), a single-stranded positive RNA virus, primarily infects cardiac myocytes and is a major causative pathogen for viral myocarditis (VMC), driving cardiac inflammation and organ dysfunction. However, whether and how myocardial damage is involved in CVB3-induced VMC remains unclear. Herein, we demonstrate that the CVB3 infection of cardiac myocytes results in the release of mitochondrial DNA (mtDNA), which functions as an important driver of cardiac macrophage inflammation through the stimulator of interferon genes (STING) dependent mechanism. More specifically, the CVB3 infection of cardiac myocytes promotes the accumulation of extracellular mtDNA. Such myocardial mtDNA is indispensable for CVB3-infected myocytes in that it induces a macrophage inflammatory response. Mechanistically, a CVB3 infection upregulates the expression of the classical DNA sensor STING, which is predominantly localized within cardiac macrophages in VMC murine models. Myocardial mtDNA efficiently triggers STING signaling in those macrophages, resulting in strong NF-kB activation when inducing the inflammatory response. Accordingly, STING-deficient mice are able to resist CVB3-induced cardiac inflammation, exhibiting minimal inflammation with regard to their functional cardiac capacities, and they exhibit higher survival rates. Moreover, our findings pinpoint myocardial mtDNA as a central element driving the cardiac inflammation of CVB3-induced VMC, and we consider the DNA sensor, STING, to be a promising therapeutic target for protecting against RNA viral infections.
No takes yet. Share an insight, caveat, or question.
Qin et al. (2023) studied Coxsackievirus B3-induced viral myocarditis. STING deficiency vs. Wild-type mice was evaluated on Cardiac inflammation, myocardial function, and survival. STING deficiency in mice alleviated CVB3-induced cardiac inflammation, improved myocardial function, and increased survival rates by preventing mtDNA-driven macrophage inflammatory responses.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: